Compound and heterozygous mutations of DSG2 identified by Whole Exome Sequencing in arrhythmogenic right ventricular cardiomyopathy/dysplasia with ventricular tachycardia-Reference-Cited by-同舟云学术

Compound and heterozygous mutations of DSG2 identified by Whole Exome Sequencing in arrhythmogenic right ventricular cardiomyopathy/dysplasia with ventricular tachycardia

Published:2018-09 Issue:5 Volume:51 Page:837-843
ISSN:0022-0736
Container-title:Journal of Electrocardiology
language:en
Short-container-title:Journal of Electrocardiology

Author:

Lin Yubi,Huang Jiana,Zhao Ting,He Siqi,Huang Zifeng,Chen Xiumin,Fei Hongwen,Luo Haiying,Liu Hui,Wu Shulin,Lin Xiufang

Funder

Fund Project of Medical Science and Technology Research in Guangdong

Sun Yat-sen University

Key Clinical Specialties in Zhuhai

Science and Technology Program of Guangdong Province

Science and Technology Program of Guangzhou City

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Right ventricular cardiomyopathy and sudden death in young people;Thiene;N Engl J Med,1988

2. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?;Basso;Circulation,1996

3. Arrhythmogenic right ventricular cardiomyopathy;Basso;Circ Arrhythm Electrophysiol,2012

4. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study;Corrado;J Am Coll Cardiol,1997

5. Right ventricular dysplasia: a report of 24 adult cases;Marcus;Circulation,1982

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reactivation of PPARα alleviates myocardial lipid accumulation and cardiac dysfunction by improving fatty acid β-oxidation in Dsg2-deficient arrhythmogenic cardiomyopathy;Acta Pharmaceutica Sinica B;2023-01

2. Whole exome sequencing in Brugada and long QT syndromes revealed novel rare and potential pathogenic mutations related to the dysfunction of the cardiac sodium channel;Orphanet Journal of Rare Diseases;2022-10-27

3. Spectrum of Rare and Common Genetic Variants in Arrhythmogenic Cardiomyopathy Patients;Biomolecules;2022-07-28

4. SGLT2 inhibitor dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the HIF ‐2α signaling pathway in arrhythmogenic cardiomyopathy;The FASEB Journal;2022-06-17

5. Rare and potential pathogenic mutations of LMNA and LAMA4 associated with familial arrhythmogenic right ventricular cardiomyopathy/dysplasia with right ventricular heart failure, cerebral thromboembolism and hereditary electrocardiogram abnormality;Orphanet Journal of Rare Diseases;2022-05-07